{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:40:36Z","timestamp":1794541236350,"version":"4.9.1"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["JDR Clinical &amp; Translational Research"],"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Infections and subsequent innate immune activation may contribute to atherogenesis. Salivary lysozyme (SLZ) is a bactericidal enzyme expressed by neutrophils and macrophages in the innate immune system. SLZ hydrolyzes peptidoglycan (PGN) in the bacterial cell wall and generates muramyl dipeptide (MDP), a ligand for nucleotide-binding oligomerization domain-containing receptors that can trigger innate immune activation, which is an established pathway to atherogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We examined the association between baseline SLZ levels and cardiovascular disease (CVD) mortality in a prospective follow-up study with a median follow-up of 18.8 y.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using Cox regression analyses among 471 subjects, we evaluated the association between CVD mortality and SLZ using restricted cubic spline analyses. We compared CVD mortality in group Q1 (SLZ between 25%ile and 75%ile) and Q2 (SLZ \u2265 75%ile) to the reference group Q0 (25%ile) adjusting for age, sex, smoking status, hypertension, diabetes, dyslipidemia, and education. Next, we tested if innate immunity assessed by SLZ is independent of metabolic inflammation measured by the median C-reactive protein level (CRP). Lastly, we assessed whether anti-inflammatory cardiac medications alter the association between SLZ and CVD mortality, given that angiotensin-converting enzyme inhibitors (ACE-i) and statins are known to decrease systemic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The multivariable-adjusted hazard ratio for CVD mortality for Q1 was 2.53 (95% confidence limit [CL]: 1.38 to 4.64) and for Q2 was 2.86 (CL: 1.45 to 5.66). The association between SLZ and CVD mortality was independent of CRP level or cardiac anti-inflammatory medications. However, adjusting for some cardiac medications such as ACE-i or statins slightly increased the association between SLZ and CVD mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Oral innate immune activation assessed by SLZ was associated with an increased risk of CVD mortality. This association was independent of metabolic inflammation or anti-inflammatory actions of cardiac medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Knowledge Transfer Statement:<\/jats:title>\n                    <jats:p>The current article reports that salivary lysozymes are markers for oral innate immune activation, which is triggered by many oral infections such as aphthous ulcers, dental caries, gingivitis, and other soft-tissue infections. Our results can be used by clinicians, researchers, and policymakers. Future randomized trials are warranted to corroborate or refute the results presented in this article.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23800844261479727","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:06:04Z","timestamp":1789121164000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality"],"prefix":"10.1177","author":[{"given":"S.-J.","family":"Janket","sequence":"first","affiliation":[{"name":"Retired, Boston University H. M. Goldman School of Dental Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-8374","authenticated-orcid":false,"given":"F.","family":"Tamimi","sequence":"additional","affiliation":[{"name":"College of Dental Medicine, QU Health, Qatar University, Doha, Qatar"},{"name":"School of Dentistry, University of Jordan, Amman, Jordan"},{"name":"Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Baird","sequence":"additional","affiliation":[{"name":"Department of Neurology, SUNY Downstate Medical Center, Brooklyn, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Surakka","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Diseases, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Paolo","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-3396","authenticated-orcid":false,"given":"T.E.","family":"Van Dyke","sequence":"additional","affiliation":[{"name":"The Forsyth Institute, Center for Clinical and Translational Research, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6702-6836","authenticated-orcid":false,"given":"J.H.","family":"Meurman","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Diseases, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Ananth CV Schisterman EF. 2017. Confounding causality and confusion: the role of intermediate variables in interpreting observational studies in obstetrics. Am J Obstet Gynecol. 217(2):167\u2013175. https:\/\/doi.org\/10.1016\/j.ajog.2017.04.016","DOI":"10.1016\/j.ajog.2017.04.016"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Back M Hlawaty H Labat C Michel JB Brink C. 2007. The oral cavity and age: a site of chronic inflammation? PLoS One. 2(12):e1351. https:\/\/doi.org\/10.1371\/journal.pone.0001351","DOI":"10.1371\/journal.pone.0001351"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Beck JD et al. 2008. The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J Periodontol 79(1):90\u201396. https:\/\/doi.org\/10.1902\/jop.2008.070223","DOI":"10.1902\/jop.2008.070223"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","unstructured":"Belalcazar LM et al. 2013. Lifestyle intervention and\/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity (Silver Spring) 21(5):944\u2013950. https:\/\/doi.org\/10.1002\/oby.20431","DOI":"10.1002\/oby.20431"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Cook NR. 2011. Urinary sodium excretion and cardiovascular disease mortality. JAMA 306(10):1085; author reply 1086\u20131087. https:\/\/doi.org\/10.1001\/jama.2011.1295","DOI":"10.1001\/jama.2011.1295"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez AS et al. 2006. Metabolic syndrome insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr. 60(6):802\u2013809. https:\/\/doi.org\/10.1038\/sj.ejcn.1602384","DOI":"10.1038\/sj.ejcn.1602384"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Janket SJ et al. 2004. Asymptotic dental score and prevalent coronary heart disease. Circulation 109(9):1095\u20131100. https:\/\/doi.org\/10.1161\/01.cir.0000118497.44961.1e","DOI":"10.1161\/01.CIR.0000118497.44961.1E"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Janket SJ et al. 2014. Number of teeth C-reactive protein fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort. J Clin Periodontol 41(2):131\u2013140. https:\/\/doi.org\/10.1111\/jcpe.12192","DOI":"10.1111\/jcpe.12192"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Janket SJ Javaheri H Ackerson LK Ayilavarapu S Meurman JH. 2015. Oral infections metabolic inflammation genetics and cardiometabolic diseases. J Dent Res 94(9 Suppl):119s\u2013127s. https:\/\/doi.org\/10.1177\/0022034515580795","DOI":"10.1177\/0022034515580795"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Kushner I. 2001. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med. 68(6):535\u2013537. https:\/\/doi.org\/10.3949\/ccjm.68.6.535","DOI":"10.3949\/ccjm.68.6.535"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Lertsirivorakul J Petsongkram B Chaiyarit P Klaynongsruang S Pitiphat W. 2015. Salivary lysozyme in relation to dental caries among Thai preschoolers. J Clin Pediatr Dent. 39(4):343\u2013347. https:\/\/doi.org\/10.17796\/1053-4628-39.4.343","DOI":"10.17796\/1053-4628-39.4.343"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Libby P Everett BM. 2019. Novel antiatherosclerotic therapies. Arterioscler Thromb Vasc Biol. 39(4):538\u2013545. https:\/\/doi.org\/10.1161\/atvbaha.118.310958","DOI":"10.1161\/ATVBAHA.118.310958"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Lipsky AM Greenland S. 2022. Causal directed acyclic graphs. JAMA. 327(11):1083\u20131084. https:\/\/doi.org\/10.1001\/jama.2022.1816","DOI":"10.1001\/jama.2022.1816"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Ragland SA Criss AK. 2017. From bacterial killing to immune modulation: recent insights into the functions of lysozyme. PLoS Pathog. 13(9):e1006512. https:\/\/doi.org\/10.1371\/journal.ppat.1006512","DOI":"10.1371\/journal.ppat.1006512"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Sen D. K. Sarin G. S. (1986). Biological variations of lysozyme concentration in the tear fluids of healthy persons. Br J Ophthalmol. 70(4): 246\u2013248. https:\/\/doi: 210.1136\/bjo.1170.1134.1246","DOI":"10.1136\/bjo.70.4.246"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Sharma A Subramaniam P Moiden S. 2017. Analysis of salivary IgA amylase lactoferrin and lysozyme before and after comprehensive dental treatment in children: a prospective study. Contemp Clin Dent. 8(4):526\u2013530. https:\/\/doi.org\/10.4103\/ccd.ccd_103_17","DOI":"10.4103\/ccd.ccd_103_17"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Silhavy TJ Kahne D Walker S. 2010. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2(5). https:\/\/doi.org\/10.1101\/cshperspect.a000414","DOI":"10.1101\/cshperspect.a000414"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Turvey SE Broide DH. 2010. Innate immunity. J Allergy Clin Immunol. 125(2 Suppl 2):S24\u2013S32. https:\/\/doi.org\/10.1016\/j.jaci.2009.07.016","DOI":"10.1016\/j.jaci.2009.07.016"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"van Zwieten A et al. 2022. Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer. J Clin Epidemiol. 149:127\u2013136. https:\/\/doi.org\/10.1016\/j.jclinepi.2022.05.021","DOI":"10.1016\/j.jclinepi.2022.05.021"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Wolf AJ Underhill DM. 2018. Peptidoglycan recognition by the innate immune system. Nat Rev Immunol. 18(4):243\u2013254. https:\/\/doi.org\/10.1038\/nri.2017.136","DOI":"10.1038\/nri.2017.136"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Zhu M et al. 2014. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukoc Biol. 96(2):349\u2013357. https:\/\/doi.org\/10.1189\/jlb.4a0214-095r","DOI":"10.1189\/jlb.4A0214-095R"}],"container-title":["JDR Clinical &amp; Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23800844261479727","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23800844261479727","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23800844261479727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:18:16Z","timestamp":1789323496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23800844261479727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":21,"alternative-id":["10.1177\/23800844261479727"],"URL":"https:\/\/doi.org\/10.1177\/23800844261479727","relation":{},"ISSN":["2380-0844","2380-0852"],"issn-type":[{"value":"2380-0844","type":"print"},{"value":"2380-0852","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"23800844261479727"}}